GR3022070T3 - New therapeutic uses of phthalazinone-derivatives - Google Patents

New therapeutic uses of phthalazinone-derivatives

Info

Publication number
GR3022070T3
GR3022070T3 GR960403515T GR960403515T GR3022070T3 GR 3022070 T3 GR3022070 T3 GR 3022070T3 GR 960403515 T GR960403515 T GR 960403515T GR 960403515 T GR960403515 T GR 960403515T GR 3022070 T3 GR3022070 T3 GR 3022070T3
Authority
GR
Greece
Prior art keywords
phthalazinone
derivatives
therapeutic uses
new therapeutic
control
Prior art date
Application number
GR960403515T
Other languages
Greek (el)
English (en)
Inventor
Juergen Prof Engel
Bernhard Dr Kutscher
Ilona Dr Fleischhauer
Stefan Prof Szelenyi
Peter Dr Metzenauer
Ulrich Dr Werner
Original Assignee
Asta Medica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica Ag filed Critical Asta Medica Ag
Publication of GR3022070T3 publication Critical patent/GR3022070T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
GR960403515T 1992-10-02 1996-12-18 New therapeutic uses of phthalazinone-derivatives GR3022070T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4233113 1992-10-02

Publications (1)

Publication Number Publication Date
GR3022070T3 true GR3022070T3 (en) 1997-03-31

Family

ID=6469448

Family Applications (1)

Application Number Title Priority Date Filing Date
GR960403515T GR3022070T3 (en) 1992-10-02 1996-12-18 New therapeutic uses of phthalazinone-derivatives

Country Status (18)

Country Link
US (1) US5556856A (cg-RX-API-DMAC7.html)
EP (1) EP0590551B1 (cg-RX-API-DMAC7.html)
JP (1) JP3623975B2 (cg-RX-API-DMAC7.html)
CN (1) CN1088435A (cg-RX-API-DMAC7.html)
AT (1) ATE144708T1 (cg-RX-API-DMAC7.html)
AU (1) AU666773B2 (cg-RX-API-DMAC7.html)
CA (1) CA2107548A1 (cg-RX-API-DMAC7.html)
CZ (1) CZ199593A3 (cg-RX-API-DMAC7.html)
DE (1) DE59304351D1 (cg-RX-API-DMAC7.html)
DK (1) DK0590551T3 (cg-RX-API-DMAC7.html)
ES (1) ES2096168T3 (cg-RX-API-DMAC7.html)
GR (1) GR3022070T3 (cg-RX-API-DMAC7.html)
HU (1) HUT65353A (cg-RX-API-DMAC7.html)
MX (1) MX9306120A (cg-RX-API-DMAC7.html)
RU (1) RU2106143C1 (cg-RX-API-DMAC7.html)
SK (1) SK104493A3 (cg-RX-API-DMAC7.html)
UA (1) UA26953C2 (cg-RX-API-DMAC7.html)
ZA (1) ZA937315B (cg-RX-API-DMAC7.html)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6162616A (en) * 1997-04-16 2000-12-19 Millennium Pharmaceuticals, Inc. Multidrug resistance-associated polypeptide
US7151102B2 (en) 2000-10-30 2006-12-19 Kudos Pharmaceuticals Limited Phthalazinone derivatives
BR0213989A (pt) * 2001-11-07 2005-03-01 Pharmacia Corp Métodos para promover a absorção e acúmulo nuclear de poliamidas em células eucarióticas
DE60335359D1 (de) 2002-04-30 2011-01-27 Kudos Pharm Ltd Phthalazinonderivate
GB0305681D0 (en) 2003-03-12 2003-04-16 Kudos Pharm Ltd Phthalazinone derivatives
US7449464B2 (en) 2003-03-12 2008-11-11 Kudos Pharmaceuticals Limited Phthalazinone derivatives
US7294701B2 (en) * 2003-04-02 2007-11-13 Technion Research & Development Foundation Ltd. Antibody fragment capable of modulating multidrug resistance and compositions and kits and methods using same
GB0419072D0 (en) 2004-08-26 2004-09-29 Kudos Pharm Ltd Phthalazinone derivatives
GB0428111D0 (en) * 2004-12-22 2005-01-26 Kudos Pharm Ltd Pthalazinone derivatives
GB0521373D0 (en) 2005-10-20 2005-11-30 Kudos Pharm Ltd Pthalazinone derivatives
US20090105225A1 (en) * 2006-04-20 2009-04-23 Glaxo Group Limited 2-Substituted 4-Benzylphthalazinone Derivatives as Histamine H1 and H3 Antagonists
JP2009541217A (ja) * 2006-06-15 2009-11-26 クドス ファーマシューティカルズ リミテッド Ｐａｒｐ阻害剤としての２−オキシベンズアミド誘導体
CN101484436A (zh) * 2006-06-15 2009-07-15 库多斯药物有限公司 作为parp抑制剂的2-氧基杂芳基酰胺衍生物
US20090181951A1 (en) * 2006-06-15 2009-07-16 Kudos Pharmaceuticals Limited Parp inhibitors
UY30639A1 (es) 2006-10-17 2008-05-31 Kudos Pharm Ltd Derivados sustituidos de 2h-ftalazin-1-ona, sus formas cristalinas, proceso de preparacion y aplicaciones
WO2008074803A2 (en) * 2006-12-20 2008-06-26 Glaxo Group Limited 4-benzyl-l ( 2h) -phthalazinones as h1 receptor antagonists
US20080280910A1 (en) * 2007-03-22 2008-11-13 Keith Allan Menear Phthalazinone derivatives
TW200900396A (en) * 2007-04-10 2009-01-01 Kudos Pharm Ltd Phthalazinone derivatives
US20090023727A1 (en) * 2007-07-05 2009-01-22 Muhammad Hashim Javaid Phthalazinone derivatives
EP2188278A1 (en) 2007-09-14 2010-05-26 AstraZeneca AB Phthalazinone derivatives
US20100216799A1 (en) * 2007-10-11 2010-08-26 Glaxo Group Limited Phthalazine and pyrido[3,4-d]pyridazine compounds as h1 receptor antagonists
EP2212296B1 (en) 2007-10-17 2014-12-03 Kudos Pharmaceuticals Limited 4- [3- (4-cyclopropanecarbonyl-piperazine-i-carbonyl) -4 -fluoro-benzyl]-2h-phthalaz in-1-one
AR070221A1 (es) 2008-01-23 2010-03-25 Astrazeneca Ab Derivados de ftalazinona inhibidores de polimerasas, composiciones farmaceuticas que los contienen y usos de los mismos para prevenir y/o tratar tumores cancerigenos,lesiones isquemicas y otras enfermedades asociadas.
CN102238945B (zh) 2008-10-07 2014-10-29 阿斯利康(英国)有限公司 药物制剂514
UY32790A (es) * 2009-07-15 2011-02-28 Astrazeneca Ab Compuesto de ftalazinona
US9783529B2 (en) 2013-03-13 2017-10-10 Flatley Discovery Lab, Llc Pyridazinone compounds and methods for the treatment of cystic fibrosis

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3677322D1 (de) * 1985-11-11 1991-03-07 Asta Pharma Ag 4-benzyl-1-(2h)-phthalazinon-derivate.
JPH0667844B2 (ja) * 1987-03-06 1994-08-31 エーザイ株式会社 虚血性心疾患の治療・予防剤
US5110814A (en) * 1989-01-11 1992-05-05 Asta Pharma Ag Azelastine and its salts used to combat psoriasis

Also Published As

Publication number Publication date
CA2107548A1 (en) 1994-04-03
CZ199593A3 (en) 1994-04-13
ZA937315B (en) 1994-04-22
EP0590551A2 (de) 1994-04-06
ES2096168T3 (es) 1997-03-01
EP0590551B1 (de) 1996-10-30
DE59304351D1 (de) 1996-12-05
SK104493A3 (en) 1994-08-10
EP0590551A3 (cg-RX-API-DMAC7.html) 1994-08-31
AU666773B2 (en) 1996-02-22
JPH06312928A (ja) 1994-11-08
HUT65353A (en) 1994-05-02
AU4876993A (en) 1994-04-14
MX9306120A (es) 1994-04-29
UA26953C2 (uk) 1999-12-29
ATE144708T1 (de) 1996-11-15
CN1088435A (zh) 1994-06-29
JP3623975B2 (ja) 2005-02-23
RU2106143C1 (ru) 1998-03-10
DK0590551T3 (da) 1997-04-21
US5556856A (en) 1996-09-17
HU9302784D0 (en) 1993-12-28

Similar Documents

Publication Publication Date Title
GR3022070T3 (en) New therapeutic uses of phthalazinone-derivatives
NO171272C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,2,4-triazolforbindelser
NO171787C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 8-azabicyclo(3.2.1)oct-2-en-forbindelser
NO171633C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cykloalkano(1.2-b)indol-sulfonamider
NO880182L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,2-dihydro-3h-indazol-3-on-derivater.
NO165922C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive estere av hexahydro-8-hydroxy-2,6-methano-2h-kinolizin-3-(4h)-on og beslektede forbindelser.
NO155490C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktivt 4-(1"-hydroksy-2"-(n-imidazolyl)etyl)bibenzyl.
NO171909C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,4-dihydropyridinderivater
NO171412C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-oksatiolan- eller 1,3-ditiolanderivater
DE3875866D1 (de) Sulfonamidolphenyl-derivate und diese enthaltende therapeutische und vorbeugend wirkende mittel gegen arrhythmie.
NO171507C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive nukleotidderivater
NO172490C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,4-disubstituerte piperazinderivater
NO171851C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktivt 6-cyano-4-(1,2-dihydro-2-okso-pyrid-1-yl)-2,2-dimetylkromen
NO874892D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-(omega-(3,5-di-t-butyl-4-hydroxyfenyl)-alkanoyl)-pyrroler og deres deoxy-analoger.
NO932391D0 (no) Angiotensin-ii reseptorantagonister for behandling av hjerterytmeforstyrrelser
NO165104C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 1, 1-disubstituerte cyklopropanderivater.
TR199901385T2 (xx) Piperidin t�revleri.
ITMI911578A1 (it) Impiego del fosfatidilinositolo per la terapia dei disturbi della depressione.
FR2701479B1 (fr) Nouveaux dérivés hétérocycliques de l'aminométhyl-4 pipéridine, leur préparation et leur application en thérapeutique.
NO171211C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksaner
AU2884489A (en) Compounds with a psychotropic action, agents containing them, and the use thereof for the treatment and prophylaxis of disorders of the central nervous system
NO162468C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 12-amino-pyridazino (4[,5[;3,4)-pyrrolo-( 2,1-a)-isokinolinderivater.
NO170282C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,4-diazepinderivater
NO306468B1 (no) Nye fosfolipid-derivater, deres fremstilling, legemiddel inneholdende derivatene og derivatenes anvendelse
NO891025L (no) Fremgangsmaate for fremstilling av nye, terapeutisk aktivesialosylglycerider.